| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/22/2013 | CN103113468A Anti-tumor protein |
| 05/22/2013 | CN103113467A PirB extracellular polypeptide and application |
| 05/22/2013 | CN103113466A Recombinant human interferon beta-1b modified by polyethylene glycol and preparation method of recombinant human interferon beta-1b |
| 05/22/2013 | CN103113465A Interferon-alpha mutant and polyethylene glycol derivative thereof |
| 05/22/2013 | CN103113464A Natural human erythropoietin analogue |
| 05/22/2013 | CN103113462A Shark glycoprotein, and preparation method and application thereof |
| 05/22/2013 | CN103113461A Novel defensin BD2, and gene and application thereof |
| 05/22/2013 | CN103113458A Hepatitis c virus B-cell epitope peptide PUHI34 and application thereof |
| 05/22/2013 | CN103113457A Antagonistic peptide SA-12 and application thereof in medicament for treating breast cancer |
| 05/22/2013 | CN103113456A Stiff silkworm polypeptide with antiplatelet aggregation activity as well as preparation method and application of stiff silkworm polypeptide |
| 05/22/2013 | CN103110958A Application of TT1 gene in preparation of medicines for treating tumors |
| 05/22/2013 | CN103110956A Method for preparing glucose-responsive insulin-self-regulating-release carrier |
| 05/22/2013 | CN103110954A Cholesterol-modified biodegradable polycation carrier as well as preparation method and application thereof |
| 05/22/2013 | CN103110952A Microwave-assisted preparation method of hydroxylapatite nanometer structure porous microspheres |
| 05/22/2013 | CN103110944A Methods of administering anti-TNF alpha antibodies |
| 05/22/2013 | CN103110938A Autologous biomedical fibrin glue preparation for plugging digestive tract fistula as well as preparation method and application of autologous biomedical fibrin glue preparation |
| 05/22/2013 | CN103110937A Skin-wound disinfecting cleaning solution prepared from marine organisms |
| 05/22/2013 | CN103110936A Biological preparation for promoting quick growth and repair of skin tissue |
| 05/22/2013 | CN103110935A Hydrolyzed collagen liposome for local skin and preparation method thereof |
| 05/22/2013 | CN103110934A Method for treating diabetic gangrene |
| 05/22/2013 | CN103110933A Elcatonin composition and preparation method thereof |
| 05/22/2013 | CN103110932A Novel application of HIP-55 (hematopoietic progenitor kinase 1 [HPK1]-interacting protein of 55kDa) |
| 05/22/2013 | CN103110931A Method for preparing romidepsin lipidosome |
| 05/22/2013 | CN103110930A Lead-removing composition and preparation method thereof |
| 05/22/2013 | CN103110929A Pharmaceutical composition of mildronate and lisinopril and preparation method thereof |
| 05/22/2013 | CN103110928A Preparation method of traditional Chinese medicine prescription oral liquid for inhibiting human immunodeficiency virus (HIV) |
| 05/22/2013 | CN103110668A Transdermal sustained-release drug delivery system and preparation and application method thereof |
| 05/22/2013 | CN103110585A Method for preparing spirulina polypeptide-chitosan nano particles |
| 05/22/2013 | CN103110577A SMANCS (Styrene Maleic Acid Neocarzinostatin) oily preparation, preparation method and application |
| 05/22/2013 | CN102718857B Denatured protein powder and brain protein hydrolyzate prepared from same |
| 05/22/2013 | CN102397533B Compound propolis composition for treating livestock egg drop syndrome and preparation method thereof |
| 05/22/2013 | CN102397532B Compound propolis composition for treating muscovy duck parvovirus disease and preparation method thereof |
| 05/22/2013 | CN102397530B Compound propolis composition for treating avian infectious encephalomyelitis and preparation method thereof |
| 05/22/2013 | CN102382187B FBXL15 protein fragment, coding gene thereof, and application of FBXL15 protein fragment and coding gene |
| 05/22/2013 | CN102242124B Modified Keratinocyte growth factor gene and its expression in yeast |
| 05/22/2013 | CN102159192B Preparation method of biodegradable micro-particles containing drugs |
| 05/22/2013 | CN102139097B Pharmaceutical composition for treating cancers and preparation method thereof |
| 05/22/2013 | CN101934069B Application of neuroglobin in promoting neurite growth |
| 05/22/2013 | CN101917967B Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes |
| 05/22/2013 | CN101890157B Application of gastrin in inhibiting gastrointestinal tumor cells |
| 05/22/2013 | CN101848725B 组合物 The composition |
| 05/22/2013 | CN101506223B 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 05/22/2013 | CN101489573B Methods for treating autoimmune diseases using a TACI-Ig fusion molecule |
| 05/22/2013 | CN101355928B Compositions and methods for cancer immunotherapy |
| 05/22/2013 | CN101010094B Guanylhydrazone salts, compositions, processes of making and methods of using |
| 05/21/2013 | US8445647 Modified exendins and exendin agonists |
| 05/21/2013 | US8445644 ErbB interface peptidomimetics and methods of use thereof |
| 05/21/2013 | US8445638 Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells |
| 05/21/2013 | US8445636 Antimicrobial and anticancer lipopeptides |
| 05/21/2013 | US8445633 Peptide having bindability with adiponectin, analysis method utilizing same peptide, and analysis device utilizing same peptide |
| 05/21/2013 | US8445632 Selective poly-N-substituted glycine antibiotics |
| 05/21/2013 | US8445449 Method and peptide for regulating cellular activity |
| 05/21/2013 | US8445448 FVIII peptides and their use in tolerising haemophiliacs |
| 05/21/2013 | US8445447 B7-DC variants immunogenic compositions and methods of use thereof |
| 05/21/2013 | US8445446 Unnatural reactive amino acid genetic code additions |
| 05/21/2013 | US8445445 Method of promoting hair growth using FGFR4 extracellular domains |
| 05/21/2013 | US8445444 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 05/21/2013 | US8445442 CCL18 and CCL3 methods and compositions for detecting and treating cancer |
| 05/21/2013 | US8445441 Inhibitors of BCL-2 |
| 05/21/2013 | US8445440 Dimeric IAP inhibitors |
| 05/21/2013 | US8445439 Itch suppressant |
| 05/21/2013 | US8445438 Compositions comprising capture peptides for A β-amyloid peptide |
| 05/21/2013 | US8445437 Treatment and prevention of cardiovascular disease using mast cell stabilizers |
| 05/21/2013 | US8445436 Oxytocin and melatonin compositions and associated methods for inducing labor |
| 05/21/2013 | US8445435 Mast cell stabilizers in the treatment of obesity |
| 05/21/2013 | US8445433 Synthesis of glucagon-like peptide |
| 05/21/2013 | US8445432 Neurturin molecules |
| 05/21/2013 | US8445431 Ligands having metal binding ability and targeting properties |
| 05/21/2013 | US8445430 Cyclic carboxamide compounds and analogues thereof as of hepatitis C virus |
| 05/21/2013 | US8445429 Lactoferrin and neuronal health and development in the infant gut |
| 05/21/2013 | US8445428 Plant derived antibiotic peptide rich in glycine |
| 05/21/2013 | US8445427 Endotoxin adsorbent, and method for removing endotoxin using the same |
| 05/21/2013 | US8445425 Urocortin-III and uses thereof |
| 05/21/2013 | US8445268 Her-2/neu DNA vaccine having anti-cancer activity |
| 05/21/2013 | US8445245 Mutant MT-SP1 proteases with altered substrate specificity or activity |
| 05/21/2013 | US8445237 RNA interference mediating small RNA molecules |
| 05/21/2013 | US8445234 Methods of making VEGF-D polypeptides |
| 05/21/2013 | US8445227 N-acetylglucosaminyltransferase III expression in lower eukaryotes |
| 05/21/2013 | US8445006 Biomolecular coating for implants |
| 05/21/2013 | US8444995 Peptide sequences and compositions |
| 05/21/2013 | US8444990 Antibody-induced apoptosis |
| 05/21/2013 | US8444987 Compositions and methods for the diagnosis and treatment of immune disorders |
| 05/21/2013 | US8444979 Antibodies that inhibit TSLP activity |
| 05/21/2013 | US8444964 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/21/2013 | US8444963 Tumor specific delivery of therapeutic agents via liposomase |
| 05/21/2013 | US8444957 Methods of screening for neoplastic disease states |
| 05/21/2013 | US8444417 Methods for treating dental diseases, disorders, and injuries |
| 05/21/2013 | US8443799 Dry powder inhalation system for transpulmonary administration |
| 05/21/2013 | CA2679452C Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue |
| 05/21/2013 | CA2594411C Peptidic biaryl antibacterial compounds comprising one or more basic amino acids |
| 05/21/2013 | CA2562957C Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment |
| 05/21/2013 | CA2519285C Papanicolau staining process |
| 05/21/2013 | CA2518541C Gonadal function improving agents |
| 05/21/2013 | CA2477675C Immunizing composition and method for inducing an immune response against the .beta.-secretase cleavage site of amyloid precursor protein |
| 05/21/2013 | CA2459869C A system for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer |
| 05/21/2013 | CA2436666C Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/21/2013 | CA2412436C Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/21/2013 | CA2401638C Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 05/21/2013 | CA2399080C Humanized anti-ccr2 antibodies and methods of use therefor |
| 05/21/2013 | CA2360146C Methods for inhibiting brain tumor growth by using selected integrin antagonists |